ALL PRO-LIFE TODAY REPORT 11/23/2011

Wednesday, November 23, 2011   Thanksgiving: Human Rights and the Confused           Thanksgiving is a day to reflect on the immense blessings in our lives. We do so knowing that all is possible only through Our Lord. Yet we long for the day when we will give thanks for laws that finally recognize that every human being, no matter how he is created or what stage of life he is in, has value and is protected under the law. Today's commentary addresses this and gives us Judie Brown's insights.                 [ Read the full article  here. ]                  HEADLINES Planned Parenthood lies about itself Washington Examiner  In 1997, I began working at a Boston Planned Parenthood clinic as a young, idealistic college student who strongly believed in what I had been told about the organization, that I would be helping other young women access safe and affordable health care.  But I quickly came to learn that the message Planned Parenthood advertised did not reflect reality. I was disillusioned by the betrayal that was perpetrated against patients and the public alike   Doctors warn of potentially fatal complications in fertility treatments The Gazette     Women undergoing fertility treatments are being warned of a rare but dangerous condition called 'ovarian hyper-stimulation syndrome.' Injectable drugs used to stimulate a woman's ovaries to produce multiple eggs for fertilization can lead to ovarian hyper-stimulation syndrome - a condition in which the ovaries swell and fluid leaks into the abdominal cavity and chest. All the news that's fit to forget: Why you're not hearing much about embryonic stem cells these days Life Site News     For years, the media touted the promise of embryonic stem cells. Year after year, Geron Corporation announced that its embryonic stem cell treatment for acute spinal cord injury would receive FDA approval "next year" for human testing. And year after year, the media dutifully informed readers and viewers that cures were imminent. When the FDA finally did approve a tiny human trial for 10 patients in January 2009, the news exploded around the world. This was it: The era of embryonic stem cell therapy had arrived!  Not exactly. Last week, Geron issued a terse statement announcing it was not only canceling the study, but abandoning the embryonic stem cell field altogether for financial reasons.